Ramius Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,900
Closed -$3.05M 325
2022
Q2
$3.05M Buy
+20,900
New +$3.05M 1.51% 14